Metasul Femoral Head - indicated for total hip arthroplasty for treatment of patient conditions ...
FDA Device Recall #Z-1136-2015 — Class II — December 17, 2014
Recall Summary
| Recall Number | Z-1136-2015 |
| Classification | Class II — Moderate risk |
| Date Initiated | December 17, 2014 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Zimmer Gmbh |
| Location | Winterthur, N/A |
| Product Type | Devices |
| Quantity | 16 |
Product Description
Metasul Femoral Head - indicated for total hip arthroplasty for treatment of patient conditions of non-inflammatory degenerative joint disease.
Reason for Recall
Potential compromise of the inner sterile tray. If a compromised tray is detected, a delay in surgery may result. If undetected breach in both the inner and outer trays were to occur, and there is contamination present, a periprosthetic infection is possible, which could lead to revision.
Distribution Pattern
Domestic: AK, AL, AR, AZ, CA, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MS, MA, MD, ME, MI, MN, MO, NC, ND, NE, NJ, NM, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WI, WV, WY International: Canada, Japan
Lot / Code Information
Item numbers: 734028800 Lot #'s: 61487614
Other Recalls from Zimmer Gmbh
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-3132-2024 | Class II | Biolox Option Taper Sleeve, Type 1 Taper, Stand... | Aug 8, 2024 |
| Z-3133-2024 | Class II | Biolox Option Taper Sleeve, Type 1 Taper, -6mm ... | Aug 8, 2024 |
| Z-1793-2021 | Class II | Zimmer Natural Nail- ZNN Cephalomedullary Short... | May 7, 2021 |
| Z-1792-2021 | Class II | Zimmer Natural Nail -ZNN Cephalomedullary Short... | May 7, 2021 |
| Z-2762-2019 | Class II | Sidus Stem-Free Shoulder Humeral Head 50-18 It... | Aug 21, 2019 |
Frequently Asked Questions
Sterility recalls for medical devices vary in severity. If you have already had a procedure using a potentially non-sterile device, contact your healthcare provider immediately — you may need monitoring for signs of infection. Symptoms to watch for include fever, redness or swelling at the surgical site, unusual pain, or discharge. For devices that have not yet been used, they should be quarantined and returned to the manufacturer per the recall notice. Non-sterile implants can cause serious infections; early detection and treatment are critical.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.